Literature DB >> 16828254

Different effects of two cyclic chalcone analogues on cell cycle of Jurkat T cells.

Zsuzsanna Rozmer1, Timea Berki, Pál Perjési.   

Abstract

It has been previously shown that the cyclic chalcone analogues E-2-(4'-methoxybenzylidene)- (2) and E-2-(4'-methylbenzylidene)-1-benzusuberone (3) inhibited proliferation of various murine and human tumor cells. In order to gain new insights into the cytotoxic mechanism of the two compounds detection of apoptosis and necrosis of Jurkat T cells exposed to 2 and 3 were performed by flow cytometry using the Annexin V-FITC and propidium iodide double staining method. Analysis of the DNA histograms at 8, 24 and 48 h exposure times showed that near equitoxic doses of 2 and 3 had different effects on the cell cycle of the exposed cells. The immediate (8h) effect of 2 was a remarkable decrease of cells in the G(0)/G(1) phase and increase in the G(2)/M phase. This effect could also be seen in the histogram of cells at the 24h time point. On the contrary, such an effect of 3 could not be observed. At the 24 and 48 h time points accumulation of sub-G(0) (apoptotic and necrotic) and hyperdiploid cells could be detected after both treatments. Incubation of 2 and 3 with reduced glutathione under cell-free conditions indicated spontaneous conjugation (non-redox) reaction at pH 7.4 and pH 9.0. Analyzing the mechanism of action the total thiol content of the cells exposed to compounds 2 and 3 was determined. Compound 2 showed to reduce the total cellular thiol level both under nutrient-free and nutrient-supplemented conditions. Under the latter conditions an increase of the total thiol level of the cells exposed to 3 for 4h could be observed. The different effect of the two compounds on the cellular thiol status might contribute to the different tumor cytotoxicity of the cyclic chalcone analogues 2 and 3. Investigation of antioxidant capacity of the compounds by monitoring time course of the Fenton-reaction initiated in vitro degradation of 2-deoxyribose indicated that both compounds displayed hydroxyl radical scavenger activity. The experiments provide further details of dual--cytotoxic and cytoprotective (chemopreventive)--effects of the compounds.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16828254     DOI: 10.1016/j.tiv.2006.05.006

Source DB:  PubMed          Journal:  Toxicol In Vitro        ISSN: 0887-2333            Impact factor:   3.500


  5 in total

Review 1.  Redox regulation of T-cell function: from molecular mechanisms to significance in human health and disease.

Authors:  Pravin Kesarwani; Anuradha K Murali; Amir A Al-Khami; Shikhar Mehrotra
Journal:  Antioxid Redox Signal       Date:  2012-10-15       Impact factor: 8.401

2.  Effect of selected dimethylaminochalcones on some mitochondrial activities.

Authors:  Janka Vašková; Renáta Reisch; Ladislav Vaško; Martina Poškrobová; Ivan Kron; Juraj Guzy; Pál Perjési
Journal:  In Vitro Cell Dev Biol Anim       Date:  2013-04-19       Impact factor: 2.416

3.  Benzylidenetetralones, cyclic chalcone analogues, induce cell cycle arrest and apoptosis in HCT116 colorectal cancer cells.

Authors:  David Drutovic; Martina Chripkova; Martina Pilatova; Peter Kruzliak; Pal Perjesi; Marek Sarissky; Monica Lupi; Giovanna Damia; Massimo Broggini; Jan Mojzis
Journal:  Tumour Biol       Date:  2014-07-10

4.  Novel [l,2,4]triazolo[3,4-a]isoquinoline chalcones as new chemotherapeutic agents: Block IAP tyrosine kinase domain and induce both intrinsic and extrinsic pathways of apoptosis.

Authors:  Magda F Mohamed; Farid M Sroor; Nada S Ibrahim; Ghada S Salem; Hadeer H El-Sayed; Marwa M Mahmoud; Menna-Allah M Wagdy; Amina M Ahmed; Aya-Allah T Mahmoud; Somia S Ibrahim; Mariam M Ismail; Sanaa Mohy Eldin; Fatma M Saleh; Hamdi M Hassaneen; Ismail A Abdelhamid
Journal:  Invest New Drugs       Date:  2020-08-28       Impact factor: 3.850

5.  Kinetic analysis of some chalcones and synthetic chalcone analogues on the fenton-reaction initiated deoxyribose degradation assay.

Authors:  Pál Perjési; Zsuzsanna Rozmer
Journal:  Open Med Chem J       Date:  2011-03-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.